skip to main content

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine Preliminary Report

Regules, J., Beigel, J., Paolino, K., et al. (2015). A Recombinant Vesicular Stomatitis Virus Ebola Vaccine Preliminary Report. The New England Journal of Medicine. 372:587-588.

The authors share results from two phase 1 trials of an attenuated, replication-competent, recombinant vesicular stomatitis virus (rVSV)-based Ebola prevention vaccine candidate.
Please Login to Add favorite.
This Article is not Rated. 0-5 Stars Please Login to rate.
You must login to add a comment.